Task: Answer the multiple choice question.
Query: Which drug has a 2.401% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a COCC(C)n1c(SCC(=O)NC(=O)Cc2ccccc2)nc2ccccc2c1=O
b CCCCN(CC)C(=O)c1ccc2c(c1)OCO2
Answer: a. COCC(C)n1c(SCC(=O)NC(=O)Cc2ccccc2)nc2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCC(C)n1c(SCC(=O)NC(=O)Cc2ccccc2)nc2ccccc2c1=O
COCC(C)n1c(SCC(=O)NC(=O)Cc2ccccc2)nc2ccccc2c1=O
N-[2-[3-(1-methoxypropan-2-yl)-4-oxoquinazolin-2-yl]sulfanylacetyl]-2-phenylacetamide